Chimerix Stock Alpha and Beta Analysis
| CMRX Stock | USD 3.97 0.04 1.02% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Chimerix. It also helps investors analyze the systematic and unsystematic risks associated with investing in Chimerix over a specified time horizon. Remember, high Chimerix's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Chimerix's market risk premium analysis include:
Beta (0.33) | Alpha 3.92 | Risk 28.71 | Sharpe Ratio 0.15 | Expected Return 4.3 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Chimerix |
Chimerix Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Chimerix market risk premium is the additional return an investor will receive from holding Chimerix long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Chimerix. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Chimerix's performance over market.| α | 3.92 | β | -0.33 |
Chimerix expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Chimerix's Buy-and-hold return. Our buy-and-hold chart shows how Chimerix performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Chimerix Market Price Analysis
Market price analysis indicators help investors to evaluate how Chimerix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Chimerix shares will generate the highest return on investment. By understating and applying Chimerix stock market price indicators, traders can identify Chimerix position entry and exit signals to maximize returns.
Chimerix Return and Market Media
The median price of Chimerix for the period between Thu, Nov 7, 2024 and Wed, Feb 5, 2025 is 2.81 with a coefficient of variation of 57.61. The daily time series for the period is distributed with a sample standard deviation of 1.29, arithmetic mean of 2.25, and mean deviation of 1.25. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Chimerix earnings missed by 0.02, revenue fell short of estimates | 11/07/2024 |
2 | Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. ... | 12/09/2024 |
3 | Chimerix soars on seeking accelerated approval for its glioma treatment to U.S. FDA | 12/10/2024 |
4 | Chimerixs Outperform Rating Reiterated at Wedbush | 12/13/2024 |
5 | Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma | 12/30/2024 |
6 | Acquisition by Andriole Michael T. of 150000 shares of Chimerix subject to Rule 16b-3 | 01/07/2025 |
7 | Chimerix to Speak Today at The White House Cancer Moonshot Forum | 01/13/2025 |
8 | Acquisition by Middleton Fred A of 60000 shares of Chimerix at 1. subject to Rule 16b-3 | 01/16/2025 |
9 | Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635 - The Manila Times | 01/24/2025 |
10 | Disposition of 2350 shares by Andriole Michael T. of Chimerix at 4.1005 subject to Rule 16b-3 | 01/30/2025 |
11 | Chimerix stock soars to 52-week high, hits 4.22 - MSN | 01/31/2025 |
About Chimerix Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Chimerix or other stocks. Alpha measures the amount that position in Chimerix has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 11.22 | 1.3K | 1.2K | 1.2K | PTB Ratio | 0.63 | 0.44 | 0.51 | 0.48 |
Chimerix Upcoming Company Events
As portrayed in its financial statements, the presentation of Chimerix's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chimerix's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Chimerix's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Chimerix. Please utilize our Beneish M Score to check the likelihood of Chimerix's management manipulating its earnings.
| 7th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 7th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Chimerix
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Chimerix Stock Analysis
When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.